FDA Approves Adalimumab Biosimilar in High-Concentration Form ...Middle East

Medscape - News
The 100-mg/mL version of adalimumab-bwwd (Hadlima) is indicated for the same seven conditions as its 50-mg/mL counterpart. FDA Approvals

Hence then, the article about fda approves adalimumab biosimilar in high concentration form was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Adalimumab Biosimilar in High-Concentration Form )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News
Time - before 8 hours & 35 minute


Latest News